IDH2 and acute myeloid leukemia: Since IDH2p.R140Q is the most common IDH mutation seen in patients with AML [4], we predicted that the combination of these two mutations would lead to AML, and generated Idh2R140Q transgenic mice that were crossed with NHD13 transgenic mice to test this hypothesis.